Patent Assignment
Reel/Frame 037093/0308
Release of Security Interest
Recorded: 2015-11-19
Pages: 8
Assignor
KREOS CAPITAL IV (UK) LIMITED
Executed: 2015-10-09
Assignee
NABRIVA THERAPEUTICS AG
LEBERSTRASSE 20, WIEN, 1110, AUSTRIA
Covered Properties
(7)
Organic Compounds
Process for the Preparation of Pleuromutilins
Organic Compounds
Pleuromutilin Derivatives and Their Use as Antimicrobials
Pleuromutilins and Process for the Preparation of Pleuromutilins
Enantiomerically Pure Amines
Process for the Preparation of Pleuromutilins
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 12, 2008
From: MANG, ROSEMARIE; BERNER, HEINZ
To: NABRIVA THERAPEUTICS AG
Reel/Frame 020933/0554 →
Assignment of Assignor's Interest
May 15, 2009
From: MACHER, INGOLF; BERGER, ANDREAS; DE CRISTOFORO, MARTIN
To: NABRIVA THERAPEUTICS AG
Reel/Frame 022691/0682 →
Assignment of Assignor's Interest
Jan 29, 2010
From: THIRRING, KLAUS; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023873/0791 →
Assignment of Assignor's Interest
Mar 11, 2010
From: THIRRING, KLAUS; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 024069/0305 →
Assignment of Assignor's Interest
Oct 29, 2012
From: MACHER, INGOLF; BERGER, ANDREAS; DE CRISTOFORO, MARTIN
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029205/0095 →
Assignment of Assignor's Interest
Nov 27, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE; BULUSU, ATCHYUTA RAMA CHANDRA MURTY
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029355/0554 →
Assignment of Assignor's Interest
Dec 10, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029439/0875 →
Lien
Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Corrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement.
Dec 2, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037190/0424 →
Change of Name
May 17, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047658/0862 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Assignment of Assignor's Interest
Jan 9, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069806/0458 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →